vs
Side-by-side financial comparison of Agilent Technologies (A) and LESAKA TECHNOLOGIES INC (LSAK). Click either name above to swap in a different company.
LESAKA TECHNOLOGIES INC is the larger business by last-quarter revenue ($3.0B vs $1.8B, roughly 1.7× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 0.0%, a 16.9% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 0.2%). Over the past eight quarters, LESAKA TECHNOLOGIES INC's revenue compounded faster (341.6% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.
A vs LSAK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $3.0B |
| Net Profit | $305.0M | $437.0K |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 2.2% |
| Net Margin | 17.0% | 0.0% |
| Revenue YoY | 7.0% | 0.2% |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 26 | — | $3.0B | ||
| Q2 26 | — | $3.1B | ||
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $178.7M | ||
| Q3 25 | $1.7B | $171.4M | ||
| Q2 25 | $1.7B | $168.5M | ||
| Q1 25 | $1.7B | $161.4M | ||
| Q4 24 | $1.7B | $176.2M |
| Q3 26 | — | $437.0K | ||
| Q2 26 | — | $3.6M | ||
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $3.6M | ||
| Q3 25 | $336.0M | $-4.3M | ||
| Q2 25 | $215.0M | $-28.4M | ||
| Q1 25 | $318.0M | $-22.1M | ||
| Q4 24 | $351.0M | $-32.5M |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 31.4% | ||
| Q3 25 | 51.1% | 30.9% | ||
| Q2 25 | 51.9% | 28.9% | ||
| Q1 25 | 53.5% | 27.5% | ||
| Q4 24 | 53.9% | 25.7% |
| Q3 26 | — | 2.2% | ||
| Q2 26 | — | 1.2% | ||
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 1.2% | ||
| Q3 25 | 20.7% | 0.2% | ||
| Q2 25 | 18.0% | -16.7% | ||
| Q1 25 | 22.4% | 0.4% | ||
| Q4 24 | 24.0% | 0.3% |
| Q3 26 | — | 0.0% | ||
| Q2 26 | — | 0.1% | ||
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 2.0% | ||
| Q3 25 | 19.3% | -2.5% | ||
| Q2 25 | 12.9% | -16.9% | ||
| Q1 25 | 18.9% | -13.7% | ||
| Q4 24 | 20.6% | -18.4% |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.04 | ||
| Q3 25 | $1.18 | $-0.05 | ||
| Q2 25 | $0.75 | $-0.40 | ||
| Q1 25 | $1.11 | $-0.27 | ||
| Q4 24 | $1.23 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $1.5B |
| Total DebtLower is stronger | $3.0B | $3.2B |
| Stockholders' EquityBook value | $6.9B | — |
| Total Assets | $12.8B | $11.5B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 26 | — | $1.5B | ||
| Q2 26 | — | $1.2B | ||
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $69.5M | ||
| Q3 25 | $1.5B | $72.2M | ||
| Q2 25 | $1.5B | $76.5M | ||
| Q1 25 | $1.5B | $71.0M | ||
| Q4 24 | $1.3B | $60.6M |
| Q3 26 | — | $3.2B | ||
| Q2 26 | — | $3.4B | ||
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $216.8M | ||
| Q3 25 | $3.4B | $208.1M | ||
| Q2 25 | $3.3B | $200.8M | ||
| Q1 25 | $3.3B | $194.7M | ||
| Q4 24 | $3.3B | $148.7M |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $180.6M | ||
| Q3 25 | $6.4B | $170.4M | ||
| Q2 25 | $6.1B | $161.6M | ||
| Q1 25 | $6.0B | $185.2M | ||
| Q4 24 | $5.9B | $193.3M |
| Q3 26 | — | $11.5B | ||
| Q2 26 | — | $11.7B | ||
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $704.6M | ||
| Q3 25 | $12.2B | $652.9M | ||
| Q2 25 | $12.2B | $653.7M | ||
| Q1 25 | $11.9B | $649.2M | ||
| Q4 24 | $11.8B | $640.6M |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 1.20× | ||
| Q3 25 | 0.53× | 1.22× | ||
| Q2 25 | 0.55× | 1.24× | ||
| Q1 25 | 0.56× | 1.05× | ||
| Q4 24 | 0.57× | 0.77× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-10.9M | ||
| Q3 25 | $362.0M | $8.9M | ||
| Q2 25 | $221.0M | $-9.1M | ||
| Q1 25 | $431.0M | $10.7M | ||
| Q4 24 | $481.0M | $-9.2M |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $-14.8M | ||
| Q3 25 | $259.0M | $4.9M | ||
| Q2 25 | $107.0M | $-13.2M | ||
| Q1 25 | $334.0M | $7.8M | ||
| Q4 24 | $388.0M | $-15.5M |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | -8.3% | ||
| Q3 25 | 14.9% | 2.9% | ||
| Q2 25 | 6.4% | -7.8% | ||
| Q1 25 | 19.9% | 4.9% | ||
| Q4 24 | 22.8% | -8.8% |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 2.2% | ||
| Q3 25 | 5.9% | 2.3% | ||
| Q2 25 | 6.8% | 2.4% | ||
| Q1 25 | 5.8% | 1.7% | ||
| Q4 24 | 5.5% | 3.6% |
| Q3 26 | — | — | ||
| Q2 26 | — | — | ||
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | -2.99× | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
LSAK
Segment breakdown not available.
